Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Status: Unknown status Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20131
20141
20152
20168
20173
20191
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PersonGen BioTherapeutics (Suzhou) Co., Ltd.3
Chinese PLA General Hospital2
Huiqiang Huang2
Academic and Community Cancer Research United1
Centaurus Biopharma Co., Ltd.1
Chongqing Precision Biotech Co., Ltd1
Jichi Medical University1
Northwestern University1
Ruijin Hospital1
Senesco Technologies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse21
Lymphoma, Mantle-Cell10
Leukemia, Lymphocytic, Chronic, B-Cell9
Lymphoma, Follicular8
Lymphoma, B-Cell6
Lymphoma4
Recurrence4
Hematologic Neoplasms3
Leukemia, Prolymphocytic, B-Cell3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.